CYP2C19 and Stroke: Thus, in the treatment of patients suffering from stroke, early CYP2C19 genotype testing and expedited reporting may be beneficial to patients, which is consistent with the opinion presented in another article [23] and may help neurologists provide more individualized precision therapy to patients.